Medicare Pilot Program Offers GLP-1 Discounts, Excludes Certain Patients

Why it matters locally: The new Medicare pilot program could offer some North Dakota seniors access to GLP-1 medications at a reduced cost, while others with specific health conditions may not qualify for these savings. This program has implications for healthcare costs and access to essential medications for the state's elderly population.

---

Medicare has introduced a pilot program aimed at streamlining access to GLP-1 medications. Under this initiative, some seniors pay $50 per month for these drugs. However, the program's structure means that many individuals with severe illnesses do not qualify for this reduced rate. Jeff La Marca, for example, received a prescription for the weight-loss drug Zepbound in January. He faced a monthly cost of $750 for the medication.